ReWalk Announces First Personal Exoskeleton Provided to Cigna Beneficiary
and YOKNEAM ILIT, Israel, April 16, 2019 /PRNewswire/ --ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), announced today that the first Cigna Corporation (Cigna) insurance beneficiary has received a ReWalk Personal 6.0 exoskeleton for use at home and in his community.
- and YOKNEAM ILIT, Israel, April 16, 2019 /PRNewswire/ --ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), announced today that the first Cigna Corporation (Cigna) insurance beneficiary has received a ReWalk Personal 6.0 exoskeleton for use at home and in his community.
- After learning about ReWalk's technology and going through the proper examinations, he became eligible to receive a ReWalk Personal 6.0 exoskeleton.
- "We continue to actively engage insurers regarding exoskeleton policy provision for eligible beneficiaries and are pleased to see recent progress with Cigna and other providers worldwide.
- In February of this year, Cigna revised its policy regarding coverage of exoskeleton medical devices for persons with spinal cord injury.